Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Jensen

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1990
Antitumor activity of the two epipodophyllotoxin derivatives VP-16 and VM-26 in preclinical systems: a comparison of in vitro and in vivo drug evaluationP B Jensen, H Roed, T Skovsgaard, et al.
The Journal of Biological Chemistry|December 5, 1998
Essential mitotic functions of DNA topoisomerase IIalpha are not adopted by topoisomerase IIbeta in human H69 cellsP Grue, A Grässer, M Sehested, et al.
Clinical Nephrology|September 10, 1999
Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormoneP B Jensen, T B Hansen, J Frystyk, et al.
Acta Pharmacologica Et Toxicologica|February 1, 1983
Pharmacokinetics and bioavailability of intravenous and intramuscular lorazepam with an adjunct test of the inattention effect in humansF Nielsen-Kudsk, T S Jensen, I Magnussen, et al.
Diabetes, Obesity & Metabolism|August 10, 2011
Foetal proglucagon processing in relation to adult appetite control: lessons from a transplantable rat glucagonoma with severe anorexiaP B Jensen, P J Larsen, C Karlsen, et al.
British Journal of Cancer|December 1, 1989
In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL)P B Jensen, L Vindeløv, H Roed, et al.
Biochemical Pharmacology|June 1, 1994
Antagonistic effect of aclarubicin on camptothecin induced cytotoxicity: role of topoisomerase IB S Sørensen, P B Jensen, M Sehested, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivityP B Jensen, H Roed, M Sehested, et al.
British Journal of Clinical Practice. Supplement|August 1, 1996
What are the clinical benefits of correcting the catabolic state in haemodialysis patients?P B Jensen, T B Hansen, H Oxhøj, et al.
Biochemical Pharmacology|May 25, 1993
Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistanceP B Jensen, B S Sørensen, M Sehested, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|January 1, 1990
Antitumor activity of the two epipodophyllotoxin derivatives VP-16 and VM-26 in preclinical systems: a comparison of in vitro and in vivo drug evaluationP B Jensen, H Roed, T Skovsgaard, et al.
The Journal of Biological Chemistry|December 5, 1998
Essential mitotic functions of DNA topoisomerase IIalpha are not adopted by topoisomerase IIbeta in human H69 cellsP Grue, A Grässer, M Sehested, et al.
Clinical Nephrology|September 10, 1999
Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormoneP B Jensen, T B Hansen, J Frystyk, et al.
Acta Pharmacologica Et Toxicologica|February 1, 1983
Pharmacokinetics and bioavailability of intravenous and intramuscular lorazepam with an adjunct test of the inattention effect in humansF Nielsen-Kudsk, T S Jensen, I Magnussen, et al.
Diabetes, Obesity & Metabolism|August 10, 2011
Foetal proglucagon processing in relation to adult appetite control: lessons from a transplantable rat glucagonoma with severe anorexiaP B Jensen, P J Larsen, C Karlsen, et al.
British Journal of Cancer|December 1, 1989
In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL)P B Jensen, L Vindeløv, H Roed, et al.
Biochemical Pharmacology|June 1, 1994
Antagonistic effect of aclarubicin on camptothecin induced cytotoxicity: role of topoisomerase IB S Sørensen, P B Jensen, M Sehested, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivityP B Jensen, H Roed, M Sehested, et al.
British Journal of Clinical Practice. Supplement|August 1, 1996
What are the clinical benefits of correcting the catabolic state in haemodialysis patients?P B Jensen, T B Hansen, H Oxhøj, et al.
Biochemical Pharmacology|May 25, 1993
Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistanceP B Jensen, B S Sørensen, M Sehested, et al.
Pageof 12